Kyle Stults
Financieel Directeur/CFO bij Verishop, Inc.
Profiel
Kyle Stults joined Novus Via in July 2012 and is responsible for investor relations and portfolio company strategy and execution.
From 2005 until 2011, Kyle was the Director of Investor Relations and Corporate Development at Martek Biosciences (formerly NASDAQ: MATK), a leader in the innovation and production of high-value products from microbial sources that promote health and wellness through nutrition.
Prior to joining Martek, Kyle was engaged in the financial sector for over six years, including being an Equity Research Analyst with Wm Smith & Company, a special situations equity research boutique based in Denver, CO, and prior to that, as an Analyst at SG Cowen Securities Corporation, a global investment bank focused on the technology and healthcare sectors.
During his tenure at SG Cowen in Boston and New York, Mr. Stults was part of the mergers and acquisitions (M&A) advisory team and was directly involved in the completion of numerous public and private transactions ranging in size from $25 million to $1 billion.
Mr. Stults is a native of Wray, Colorado, and a graduate of the University of Denver’s Daniels College of Business where he graduated cum laude with a B.S.
in Business Administration with an emphasis in Finance.
Actieve functies van Kyle Stults
| Bedrijven | Functie | Begin |
|---|---|---|
Verishop, Inc.
 Verishop, Inc. Apparel/Footwear RetailRetail Trade Verishop, Inc. operates as e-commerce platform. It offers women’s fashion, men’s fashion, free 2 day shipping, free return and exchange, and 24/7 customer care. The company was founded by Cate Khan and Imran T. Khan and is headquartered in Dallas, TX. | Financieel Directeur/CFO | 01-11-2021 |
Eerdere bekende functies van Kyle Stults
| Bedrijven | Functie | Einde |
|---|---|---|
VitriVax, Inc.
 VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | Financieel Directeur/CFO | 30-11-2021 |
Novus Via Management LLC
 Novus Via Management LLC Investment ManagersFinance Novus Via Management LLC is a venture capital firm founded in 2012. The firm is headquartered in New York. | Financieel Directeur/CFO | 31-12-2020 |
Martek Biosciences Corp.
 Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Investor Relations Contact | 31-10-2011 |
Wm Smith Securities, Inc.
 Wm Smith Securities, Inc. Investment Banks/BrokersFinance Wm Smith Securities, Inc., the brokerage arm of Wm Smith & Co. is a broker/dealer headquartered in Denver. The firm was founded in October of 1993 and offers a full array of investment services. They provide fundamental equity research to a select group of institutional clients from both the traditional and alternative investment arena. The firm primarily focuses on special situations with an emphasis on under-followed and under-valued companies. They are a member of the SIPC. | Analyst-Equity | 31-10-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Martek Biosciences Corp.
Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Health Technology |
Wm Smith Securities, Inc.
Wm Smith Securities, Inc. Investment Banks/BrokersFinance Wm Smith Securities, Inc., the brokerage arm of Wm Smith & Co. is a broker/dealer headquartered in Denver. The firm was founded in October of 1993 and offers a full array of investment services. They provide fundamental equity research to a select group of institutional clients from both the traditional and alternative investment arena. The firm primarily focuses on special situations with an emphasis on under-followed and under-valued companies. They are a member of the SIPC. | Finance |
Novus Via Management LLC
Novus Via Management LLC Investment ManagersFinance Novus Via Management LLC is a venture capital firm founded in 2012. The firm is headquartered in New York. | Finance |
Verishop, Inc.
Verishop, Inc. Apparel/Footwear RetailRetail Trade Verishop, Inc. operates as e-commerce platform. It offers women’s fashion, men’s fashion, free 2 day shipping, free return and exchange, and 24/7 customer care. The company was founded by Cate Khan and Imran T. Khan and is headquartered in Dallas, TX. | Retail Trade |
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology VitriVax, Inc. is a biotechnology company based in Boulder, CO that partners with vaccine developers to create thermostable vaccines that can be delivered in a single shot. The company's proprietary atomic layering thermostable antigen and adjuvant (alta™) technology platform enables vaccines to be shipped ly without refrigeration or freezing, last for years on the shelf, and only require one patient interaction to deliver multiple doses. The alta™ technology can be applied to a wide variety of vaccine antigens and adjuvants to protect against thermal and chemical degradation and enable controlled release, incorporating prime doses and additional booster doses in a single-shot administration. The company was founded by Robert Garcea and Theodore Randolph, and the CEO is Matthew Raider. | Health Technology |
